0001493152-23-029734.txt : 20230821
0001493152-23-029734.hdr.sgml : 20230821
20230821180018
ACCESSION NUMBER: 0001493152-23-029734
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230817
FILED AS OF DATE: 20230821
DATE AS OF CHANGE: 20230821
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nicholoudis Christos
CENTRAL INDEX KEY: 0001984816
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41765
FILM NUMBER: 231190452
MAIL ADDRESS:
STREET 1: C/O MIRA PHARMACEUTICALS, INC.
STREET 2: 900 WEST PLATT STREET, SUITE 200
CITY: TAMPA
STATE: FL
ZIP: 33606-2173
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MIRA PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001904286
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 853354547
STATE OF INCORPORATION: FL
BUSINESS ADDRESS:
STREET 1: 855 N WOLFE STREET #623-6
CITY: BALTIMORE
STATE: MD
ZIP: 21205
BUSINESS PHONE: 813-369-5150
MAIL ADDRESS:
STREET 1: 324 SOUTH HYDE PARK AVENUE, SUITE 350
CITY: TAMPA
STATE: FL
ZIP: 33606
FORMER COMPANY:
FORMER CONFORMED NAME: Mira1a Therapeutics, Inc.
DATE OF NAME CHANGE: 20220112
4
1
ownership.xml
X0508
4
2023-08-17
0
0001904286
MIRA PHARMACEUTICALS, INC.
MIRA
0001984816
Nicholoudis Christos
C/O MIRA PHARMACEUTICALS, INC.
855 N WOLFE ST., SUITE 200
BALTIMORE
MD
21205
1
0
0
0
0
Stock Options
6.50
2023-08-17
4
A
0
10000
0
A
2033-08-17
Common Stock
10000
10000
D
The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 17, 2023.
The stock options were issued to the Reporting Person on August 17,2023, pursuant to a grant under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated. The award vested in full on August 17,2023.
/s/ Michelle Yanez, Attorney-in-Fact for Christos Nicholoudis
2023-08-21